按需自适应:局部晚期肺癌个性化自适应放疗的新策略
本研究分析了26例局部晚期肺癌患者接受按需自适应(AOD)工作流的疗效,该工作流结合ETHOS系统在线自适应放疗与Halcyon单元图像引导放疗,每周自适应一次。结果显示AOD工作流多数分次可在30分钟内完成,在线自适应计划的内靶区覆盖率为99.2%,计划靶区覆盖率为93.9%,分别较非自适应计划提高2.9%和6.8%(P<.05)。
要点
- AOD工作流多数分次可在30分钟内完成,每周自适应可跟上解剖变化。
- 在线自适应计划ITV和PTV的V100%分别为99.2%和93.9%,较非自适应计划提高2.9%和6.8%(P<.05)。
- 肿瘤增长>10%时,在线自适应PTV覆盖率为93.1%,非自适应为76.4%,中位改善17.2%(P<.05)。
核心结论
- AOD工作流高效且稳健地响应局部晚期肺癌患者的解剖变化,较标准治疗提供剂量学优势,每周自适应足以跟上变化,是管理解剖变化的传统离线再计划工作流的可行替代方案。
研究设计与样本
- 研究分析了26例接受AOD工作流治疗的局部晚期肺癌患者,每周自适应一次,对工作流各环节计时以评估真实临床效率,比较自适应计划与非自适应计划靶区覆盖和危及器官剂量,并按肿瘤体积变化分层评估计划稳健性。
主要发现
- AOD工作流多数放疗分次可在30分钟内完成。
- 治疗期间内靶区平均缩小26.6%±23.3%。
- 在线自适应计划ITV和PTV的V100%分别为99.2%和93.9%,较非自适应计划分别提高2.9%和6.8%(P<.05)。
- 肿瘤增长>10%时,在线自适应PTV的V100%为93.1%,非自适应计划为76.4%,中位改善17.2%(P<.05)。
- 在线自适应计划关键危及器官约束达标率94.1%,非自适应计划为81.9%,心脏、食管和肺分别减少1.32 Gy、1.34 Gy和1.75 Gy。
关键数值与推荐
- 在线自适应计划ITV的V100%为99.2%,PTV的V100%为93.9%。
- 非自适应计划ITV和PTV的V100%分别较在线自适应计划低2.9%和6.8%(P<.05)。
- 肿瘤增长>10%时,在线自适应计划PTV的V100%为93.1%,非自适应计划为76.4%(P<.05)。
- 在线自适应计划关键危及器官约束达标率94.1%,非自适应计划为81.9%。
- 在线自适应计划较非自适应计划心脏、食管和肺剂量分别减少1.32 Gy、1.34 Gy和1.75 Gy。
临床怎么用
- 原文结论认为AOD工作流是管理局部晚期肺癌放疗中解剖变化的传统离线再计划工作流的可行替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Real-time adaptation of thoracic radiation plans is compelling because offline adaptive experiences show that tumor volumes and lung anatomy can change during therapy. We present and analyze a novel adaptive-on-demand (AOD) workflow combining online adaptive radiation therapy (o-ART) on the ETHOS system with image guided radiation therapy delivery on a Halcyon unit for conventional fractionated radiation therapy of locally advanced lung cancer (LALC). METHODS AND MATERIALS: We analyzed 26 patients with LALC treated with the AOD workflow, adapting weekly. We timed segments of the workflow to evaluate efficiency in a real-world clinic. Target coverage and organ at risk (OAR) doses were compared between adaptive plans (ADP) and nonadaptive scheduled plans (SCH). Planning robustness was evaluated by the frequency of preplanning goals achieved in ADP plans, stratified by tumor volume change. RESULTS: The AOD workflow was achievable within 30 minutes for most radiation fractions. Over the course of therapy, we observed an average 26.6% ± 23.3% reduction in internal target volume (ITV). Despite these changes, with o-ART, ITV and planning target volume (PTV) coverage (V100%) was 99.2% and 93.9% for all members of the cohort, respectively. This represented a 2.9% and 6.8% improvement over nonadaptive plans (P < .05), respectively. For tumors that grew >10%, V100% was 93.1% for o-ART and 76.4% for nonadaptive plans, representing a median 17.2% improvement in the PTV coverage (P < .05). In these plans, critical OAR constraints were met 94.1% of the time, whereas in nonadaptive plans, this figure was 81.9%. This represented reductions of 1.32 Gy, 1.34 Gy, or 1.75 Gy in the heart, esophagus, and lung, respectively. The effect was larger when tumors had shrunk more than 10%. Regardless of tumor volume alterations, the PTV/ITV coverage was achieved for all adaptive plans. Exceptional cases, where dose constraints were not met, were due to large initial tumor volumes or tumor growth. CONCLUSIONS: The AOD workflow is efficient and robust in responding to anatomic changes in LALC patients, providing dosimetric advantages over standard therapy. Weekly adaptation was adequate to keep pace with changes. This approach is a feasible alternative to conventional offline replanning workflows for managing anatomy changes in LALC radiation therapy.
引用
- Li R, Zhuang T, Montalvo S, et al. Adapt-On-Demand: A Novel Strategy for Personalized Adaptive Radiation Therapy for Locally Advanced Lung Cancer. Pract Radiat Oncol. 2024. PMID: 38579986. doi:10.1016/j.prro.2024.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。